Supplementary Information from The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context–Dependent Manner in Pediatric Acute Lymphoblastic Leukemia

MLA

William L. Carroll, et al. Supplementary Information from The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context–Dependent Manner in Pediatric Acute Lymphoblastic Leukemia. Apr. 2023. EBSCOhost, https://doi.org/10.1158/1541-7786.22517914.

APA

William L. Carroll, Nikki A. Evensen, Aristotelis Tsirigos, Xiaotu Ma, Jinghui Zhang, Patrick A. Brown, Mignon L. Loh, Jun J. Yang, Kjeld Schmiegelow, David T. Teachey, Tori J. Fuller, Takaya Moriyama, Harrison L. Kilberg, Hannah Fay, Anita Qualls, Ashfiyah Chowdhury, Shella Saint Fleur-Lominy, Gunjan Sethia, Sonali Narang, … Joanna Pierro. (2023). Supplementary Information from The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context–Dependent Manner in Pediatric Acute Lymphoblastic Leukemia. https://doi.org/10.1158/1541-7786.22517914

Chicago

William L. Carroll, Nikki A. Evensen, Aristotelis Tsirigos, Xiaotu Ma, Jinghui Zhang, Patrick A. Brown, Mignon L. Loh, et al. 2023. “Supplementary Information from The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context–Dependent Manner in Pediatric Acute Lymphoblastic Leukemia,” April. doi:10.1158/1541-7786.22517914.